Ireland
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.50 B
|
Oct. 25, 2024 | USD 85.25 | 4.23% |
|
Ireland |
|
2 |
USD 1.11 B
|
March 31, 2024 | USD 42.18 | 0.76% |
|
Ireland |
|
3 |
USD 1.07 B
|
Dec. 31, 2023 | USD 122.96 | -0.16% |
|
Ireland |
|
4 |
USD 1.02 B
|
Dec. 31, 2023 | USD 200.24 | -8.14% |
|
Ireland |
|
5 |
USD 834.32 M
|
Dec. 31, 2023 | USD 93.99 | 0.60% |
|
Ireland |
|
6 |
USD 680.11 M
|
Sept. 30, 2024 | USD 207.57 | 0.10% |
|
Ireland |
|
7 |
USD 353.31 M
|
Dec. 31, 2023 | USD 28.50 | 0.53% |
|
Ireland |
|
8 |
USD 22.69 M
|
Dec. 31, 2023 | USD 2.05 | 2.67% |
|
Ireland |
|
9 |
USD 20.21 M
|
Dec. 31, 2023 | USD 69.11 | -2.10% |
|
Ireland |
|
10 |
USD 1.18 M
|
Dec. 31, 2023 | USD 0.02 | -6.17% |
|
Ireland |
|
11 |
USD -3.53 M
|
Dec. 31, 2023 | USD 9.02 | 1.18% |
|
Ireland |
|
12 |
USD -33.44 M
|
Dec. 31, 2023 | USD 8.19 | -1.92% |
|
Ireland |
|
13 |
USD -39.34 M
|
Dec. 31, 2023 | USD 1.60 | -2.44% |
|
Ireland |
|
14 |
USD -128.51 M
|
Dec. 31, 2023 | USD 8.05 | 2.94% |
|
Ireland |
|
15 |
USD -136.72 M
|
Dec. 31, 2023 | USD 12.67 | -3.50% |
|
Ireland |
|
16 |
USD -197.70 M
|
Dec. 31, 2023 | USD 3.72 | -0.53% |
|
Ireland |
The Pharmaceuticals company in Ireland with the highest Free Cash Flow is Medtronic plc (NYSE: MDT) at USD 5.50 B.
The Pharmaceuticals company in Ireland with the lowest Free Cash Flow is Mural Oncology plc (NasdaqGM: MURA) at USD -197.70 M.
The top 10 Pharmaceuticals companies in Ireland by Free Cash Flow are Medtronic plc, Experian plc, Jazz Pharmaceuticals plc, ICON Public Limited Company, Kerry Group plc, STERIS plc, Alkermes plc, Uniphar plc, Cosmo Pharmaceuticals N.V. and Ovoca Bio plc.
The bottom 10 Pharmaceuticals companies in Ireland by Free Cash Flow are Mural Oncology plc, Prothena Corporation plc, Avadel Pharmaceuticals plc, Iterum Therapeutics plc, GH Research PLC, Malin Corporation plc, Ovoca Bio plc, Cosmo Pharmaceuticals N.V., Uniphar plc and Alkermes plc.